OOIR: Observatory of International Research

Papers

(The H4-Index of Biochimica et Biophysica Acta-Reviews on Cancer is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
The bridging role of neutrophils in the progression of inflammation-induced colorectal cancer	285
Modeling bladder cancer in the laboratory: Insights from patient-derived organoids	262
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective	220
Progress and challenges of immunotherapy in triple-negative breast cancer	197
Advances in epigenetic modifications and cervical cancer research	172
Targeted drug delivery systems in Lymphoma treatment: Advances and clinical perspectives	121
The role of protein glycosylation in colorectal cancer: From molecular pathways to clinical applications	116
Unlocking the power of innate lymphoid cell plasticity in the tumor microenvironment: A revolutionary pathway for cancer immunotherapy	108
VISTA as a context-dependent immune checkpoint: Implications for tumor immunity and autoimmune pathogenesis	103
Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?	102
Uveal melanoma modeling in mice and zebrafish	100
Nutrition and dietary restrictions in cancer prevention	99
TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance	90
Reflections on drug resistance to KRAS inhibitors and gene silencing/editing tools for targeting mutant KRAS in cancer treatment	89
ESR1 activating mutations: From structure to clinical application	80
Tumour cell-induced platelet aggregation in breast cancer: Scope of metal nanoparticles	78
miRNAs and androgen deprivation therapy for prostate cancer	74
Spatiotemporal dynamics of the pre-metastatic niche: remodeling of lung microenvironment before breast cancer metastasis and targeted intervention strategies	71
Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects	68
Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights	67
Yin yang 1: a potential regulator of immune related diseases and cancer immunity	65
Unveiling anaphylatoxins: Pioneering cancer therapies through complement system insights	65
Biomarkers in high grade serous ovarian cancer	63
Insights into the role of connexins and specialized intercellular communication pathways in breast cancer: Mechanisms and applications	59
Extracellular vesicles in cancer therapy: Roles, potential application, and challenges	58

Long non-coding RNAs: Fundamental regulators and emerging targets of cancer stem cells	56
Detection methods for mitochondrial DNA heteroplasmy and their potential single-cell applications in cancer	56
In what area of biology has a “new” type of cell death been discovered?	54
Targeting lipid metabolism in cancer metastasis	54
CCL20-CCR6 signaling in tumor microenvironment: Functional roles, mechanisms, and immunotherapy targeting	53
Transcription factors in glioblastoma – Molecular pathogenesis and clinical implications	53
Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature	52
Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer	51
Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies	51
Decoding the role of FOXP3 in esophageal cancer: Underlying mechanisms and therapeutic implications	50
Revisiting CHK1 and WEE1 kinases as therapeutic targets in cancer	49
The VEGF/VEGFR2 system in ovarian cancer: From functional to pharmacological significance	49
Exploring synthetic lethality in cancer therapy: CRISPR-Cas9 technology offers new hope	48
Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential	48
S100A8 and S100A9 in Cancer	48
Advances and prospects of mRNA vaccines in cancer immunotherapy	48
Fascin-1 in primary liver cancers, perspectives for targeted therapy	48
Integrating multi-omics proteomic approaches in deciphering the tumor microenvironment and therapeutic resistance mechanisms in prostate cancer	47
Inhibition of nucleotide excision repair proteins associated with cancer chemotherapy	47
Multiple impacts of Naa10p on cancer progression: Molecular functions and clinical prospects	47
Multifaceted roles of neutrophils in tumor microenvironment	45
Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma	45
Interleukin-21 as an adjuvant in cancer immunotherapy: Current advances and future directions	45
STIM1-mediated calcium signalling in cancer: Its relation to tumour aggressiveness and therapeutic horizons	45